Polysorbates are non-ionic surfactants, widely employed in biopharmaceutical formulations as stabilizers of therapeutic proteins. Among them, polysorbate 20 and polysorbate 80 are the most commonly used. Their complex composition not only offers unique functional properties but also poses challenges for their analytical characterization. Liquid chromatography coupled with a charged aerosol detector provides an effective approach for both quantitative and qualitative analysis. However, polysorbate degradation leads to a reduction in their concentration and the formation of by-products, both of which may compromise protein stability within a formulation. The primary degradation pathways are hydrolysis and oxidation. During drug development, it is essential to identify and evaluate all factors that may influence the quality, safety, and efficacy of the final medicinal product. Two such factors, frequently encountered during manufacturing processes, are freeze–thaw cycles and filtration, which were systematically investigated in this master’s thesis.
The results demonstrated that the number of freeze–thaw cycles applied to aqueous solutions of polysorbate 20 and 80 did not affect their concentrations. The filters that we tested are used in biopharmaceutical manufacturing for the sterilization of small product batches. The extent of polysorbate binding to filter membranes was shown to depend on both the membrane material and pore size. Given that membranes are often modified by manufacturers, it is advisable to experimentally assess the influence of filtration on the quantitative and qualitative composition of polysorbates. Current practice recommends discarding the first milliliter of filtrate to ensure consistent polysorbate content. Our findings confirmed that both concentration and composition were altered at the beginning of filtration. After approximately 0.5 mL of filtrate, concentrations stabilized and the qualitative profile closely resembled that of the unfiltered solution. These results support the suitability of the current protocol requiring the initial milliliter of filtrate to be discarded.
|